Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses
Caroline Caperton, Brian BermanDepartment of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USAAbstract: Imiquimod, an immune-modulating imidazoquinoline compound, has been approved in topical formulation for the treatment of actinic keratoses, superfic...
Saved in:
Main Authors: | Caperton CV (Author), Berman B (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rechallenge and retreatment with topical imiquimod 5% in transplant recipients: A multicenter experience on actinic keratoses and basal cell carcinomas
by: Paolo Fava, et al.
Published: (2024) -
Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment
by: Mario Valenti, et al.
Published: (2024) -
Diclofenac gel in the treatment of actinic keratoses
by: Nelson CG
Published: (2011) -
Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses
by: Khaled Ezzedine, et al.
Published: (2021) -
Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review
by: Nicole Natarelli, et al.
Published: (2023)